Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump

2 weeks ago 4

Roche lowered its 2024 maturation outlook successful February arsenic it continues to face a drop-off successful request for its Covid-19 products and a fig of its crab drugs.